Cargando…
k-RAS mutations in non-small cell lung cancer patients treated with TKIs among smokers and non-smokers: a meta-analysis
AIM OF THE STUDY: Recent studies have suggested that k-RAS mutations are related to the response to epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitions (TKIs) in advanced non-small cell lung cancer (NSCLC) treatment. The aim of this meta-analysis was to assess the relationship betwee...
Autores principales: | Jiang, Ai-Gui, Lu, Hui-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925733/ https://www.ncbi.nlm.nih.gov/pubmed/27358590 http://dx.doi.org/10.5114/wo.2016.60068 |
Ejemplares similares
-
Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers
por: Liu, Yang, et al.
Publicado: (2007) -
Dietary Antioxidants and Lung Cancer Risk in Smokers and Non-Smokers
por: Alsharairi, Naser A.
Publicado: (2022) -
The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers
por: Andrzejczak, Anna, et al.
Publicado: (2023) -
Lung cancer in non-smokers
por: Stahel, Rolf A.
Publicado: (2013) -
Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments
por: Li, Xufan, et al.
Publicado: (2018)